Mild TBI, commonly known as a concussion ... “The submission of our Investigator’s Brochure application marks a critical step forward in advancing our clinical program for ONP-002,” said ...
When our review of the role of progesterone (PROG) in brain injury was published in Future Neurology in 2006, there was no clinically available treatment for traumatic brain injury (TBI).
Oragenics submitted its Investigator's Brochure for ONP-002, preparing for a Phase II trial for mild traumatic brain injury. Oragenics, Inc., a biotechnology company based in Sarasota, Florida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results